"Biofortis is a global research organization serving innovation in nutrition, health, and microbiota studies that offers complementary, differentiating, and innovative services, including pre-clinical, clinical, and R&D research. Biofortis combines an experienced and GCP-trained staff with a strong network of scientists and key opinion leaders in various study fields such as cardiovascular, metabolic, exercise physiology, cognitive function, satiety and weight management. In addition, and with the Next Generation Sequencing (NGS) platform and bioinformatics solutions, Biofortis can characterize the different microbiomes and evaluate the safety and the efficacy of new candidate or new products."

During the past decade, Biofortis conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Biofortis" #1 sponsor was "Naturex SA" with 4 trials, followed by "Danone Research" with 2 trials sponsored, "Institut Rosell Lallemand" with 2 trials sponsored, "Lesaffre International" with 2 trials sponsored and "Lescuyer Laboratory" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Biofortis" #1 collaborator was "BioFortis" with 9 trials as a collaborator, "Biofortis Mérieux NutriSciences" with 6 trials as a collaborator, "Activ'inside" with 1 trials as a collaborator, "Atrium Innovations" with 1 trials as a collaborator and "Fruit d'Or" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Biofortis" are "Healthy" (2 trials), "Healthy Subject" (2 trials), "Irritable Bowel Syndrome" (2 trials), "Signs and Symptoms, Digestive" (2 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Biofortis" in a lesser frequency.

Most popular intervention types in "Biofortis" are "Dietary Supplement" (19 trials), "Other" (6 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Placebo (including Maltodextrin)" (2 trials), "Saccharomyces cerevisiae CNCM I-3856" (2 trials), "placebo" (2 trials) and "Active product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biofortis" are 26 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Biofortis". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Biofortis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Biofortis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 27 trials that are defined as “Not Applicable".

Biofortis has several departments that took part in Clinical trials: "Unité d'Investigation Clinique Biofortis Mérieux NutriSciences" - 2 trials